NCT02663518 A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid Tumors Status TERMINATED Phase PHASE1
NCT02659631 PF-06671008 Dose Escalation Study in Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT02656082 Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus Status COMPLETED Phase PHASE2
NCT02655419 Determine the PK and Safety and Tolerability of ATM-AVI for the Treatment of cIAIs in Hospitalized Adults (REJUVENATE) Status COMPLETED Phase PHASE2
NCT02650193 A Study Of The Safety And Effects Of One Or More Doses Of HSP-130 Injected Under The Skin In Women With Breast Cancer That Has Not Spread To Distant Sites In The Body. Status COMPLETED Phase PHASE2
NCT02636725 Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas Status COMPLETED Phase PHASE2
NCT02630706 A Study to Evaluate the Efficacy and Safety of Ertugliflozin in Asian Participants With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Monotherapy (MK-8835-012) Status COMPLETED Phase PHASE3
NCT02630693 Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT02629289 A Comparative Study to Evaluate the Effect of HSP-130, US-approved Neulasta and EU-approved Neulasta in Healthy Participants Status COMPLETED Phase PHASE1
NCT02625207 THE EFFECT OF CYP3A5 GENOTYPE ON THE PHARMACOKINETICS OF MARAVIROC Status COMPLETED Phase PHASE1
NCT02624973 PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02623049 Direct Oral Anticoagulants Pharmacodynamics in Octogenarian Patients With Atrial Fibrillation Status UNKNOWN Phase N/A
NCT02622581 Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients Status RECRUITING Phase N/A
NCT02616185 A Phase 1 Study To Evaluate Escalating Doses Of A Vaccine-Based Immunotherapy Regimen For Prostate Cancer (PrCa VBIR) Status TERMINATED Phase PHASE1
NCT02614482 Extension Study of Fesoterodine for Overactive Bladder Syndrome in Children. Status COMPLETED Phase PHASE3
NCT02613650 A Trial of mFOLFIRI With MEK162 in Patients With Advanced RAS (HRAS, NRAS, or KRAS) Positive Metastatic Colorectal Cancers Status COMPLETED Phase PHASE1
NCT02612194 LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer Status TERMINATED Phase PHASE2
NCT02609828 Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy Status COMPLETED Phase PHASE3